Search results for "030227 psychiatry"

showing 10 items of 1017 documents

Differential effects of MDMA and cocaine on inhibitory avoidance and object recognition tests in rodents.

2017

Introduction Drug addiction continues being a major public problem faced by modern societies with different social, health and legal consequences for the consumers. Consumption of psychostimulants, like cocaine or MDMA (known as ecstasy) are highly prevalent and cognitive and memory impairments have been related with the abuse of these drugs. Aim The aim of this work was to review the most important data of the literature in the last 10 years about the effects of cocaine and MDMA on inhibitory avoidance and object recognition tests in rodents. Development: The object recognition and the inhibitory avoidance tests are popular procedures used to assess different types of memory. We compare th…

medicine.medical_specialtyMDMACognitive Neurosciencemedia_common.quotation_subjectN-Methyl-34-methylenedioxyamphetamineEcstasyInvestigación médicaEnsayos clínicosExperimental and Cognitive PsychologyRodentiaPublic problemInhibitory postsynaptic potential03 medical and health sciencesBehavioral Neuroscience0302 clinical medicineCocaineDopamine Uptake Inhibitorsmental disordersmedicineAvoidance LearningAnimalsDrogasPsychiatrymedia_commonMemory DisordersAdrenergic Uptake InhibitorsBehavior AnimalAddictionMDMACognitionRecognition PsychologyInhibitory avoidanceAbstinenceDifferential effects030227 psychiatryEfectos fisiológicosPsychologyEstupefaciente030217 neurology & neurosurgerymedicine.drugNeurobiology of learning and memory
researchProduct

Pharmacological treatment of sexual offenders in German outpatient treatment centers

2018

In Germany, depending on a sexual offender's culpability and the severity of the offence, he/she can be placed either in the forensic-psychiatric or the correctional system. Numbers related to the pharmacological treatment of sexual offenders for the correctional system are missing so far. In sexual offenders, the pharmacological treatment of paraphilic disorders is of special importance. The present study aimed at assessing the prevalence of pharmacological sexual offender treatment in German outpatient treatment centers supervising mainly clients from the correctional sector. An online questionnaire was sent to 112 outpatient treatment centers and 21 provided data relevant for the present…

medicine.medical_specialtyMEDLINEComputer-assisted web interviewingPharmacological treatmentGerman03 medical and health sciences0302 clinical medicineGermanyOutpatientsAmbulatory CarePrevalencemedicineHumansPharmacology (medical)PsychiatryParaphilic Disorders0505 lawParaphilic Disordersbusiness.industryMental DisordersSex Offenses05 social sciencesCriminalsDrug Utilizationlanguage.human_language030227 psychiatryPsychiatry and Mental healthMulticenter study050501 criminologylanguagebusinessFacilities and Services UtilizationSelective Serotonin Reuptake InhibitorsAntipsychotic AgentsCulpabilityInternational Clinical Psychopharmacology
researchProduct

Olanzepine-induced tardive dyskinesia

2003

Tardive dyskinesia is a serious and common motor side-effect of treatment with traditional neuroleptics, with an unknown pathophysiological basis. It affects 20-30% of patients on long-term neuroleptic therapy, with elderly patients being at higher risk ( [American Psychiatric Association, 1994][1

medicine.medical_specialtyNeuroleptic therapybusiness.industryTardive dyskinesiamedicine.diseasePirenzepine030227 psychiatry03 medical and health sciencesPsychiatry and Mental health0302 clinical medicineInternal medicinemedicine030212 general & internal medicinebusinessmedicine.drugBritish Journal of Psychiatry
researchProduct

Trigeminal Meningioma in a Patient with Tardive Dyskinesia as Only Symptom

2018

Most meningiomas are benign, encapsulated tumors (95% of the cases), generally undergoing a limited number of genetic aberrations. We present the case of a 74-year-old patient with no significant pathological history, who is admitted to the neurology ward for orofacial dyskinesias accompanied by hypoesthesia in the left hemiface, a symptomatology that had started insidiously about two months before and worsened progressively over the past 3 weeks. A cerebral MRI was performed which revealed a small mass with discrete T2 hyperintensity and T1 iso-signal compared to the gray matter located in the left pontine cistern, with a large, well-defined base at the level of the cerebral tentorium. The…

medicine.medical_specialtyNeurologyPontine cisternbusiness.industryCase ReportHypoesthesiaTardive dyskinesiamedicine.diseaseTentoriumHyperintensity030227 psychiatryMeningioma03 medical and health sciences0302 clinical medicineotorhinolaryngologic diseasesmedicineNeurosurgeryRadiologymedicine.symptomGeneral Agricultural and Biological Sciencesbusiness030217 neurology & neurosurgeryCase Reports in Neurological Medicine
researchProduct

Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: Efficacy following prior methylphenidate trea…

2016

Guanfacine extended release (GXR) and atomoxetine (ATX) are nonstimulant treatments for attention-deficit/hyperactivity disorder (ADHD). As nonstimulant treatments are often used after stimulants in ADHD, GXR was assessed relative to prior stimulant treatment in a randomized controlled trial (RCT), in which ATX was included as a reference arm, and in the open-label phase of a randomized-withdrawal study (RWS). Participants were 6–17 years old with ADHD Rating Scale version IV (ADHD-RS-IV) scores ≥32 and Clinical Global Impressions – Severity scores ≥4. RCT participants received dose-optimized GXR (1–7 mg/day), ATX (10–100 mg/day), or placebo for 10–13 weeks. RWS participants received dose-o…

medicine.medical_specialtyNeuropsychiatric Disease and Treatmentmedicine.medical_treatmenteffectivenessmethylphenidateNeurosciences. Biological psychiatry. NeuropsychiatryPlacebolaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialRating scalelawInternal medicinemental disordersmedicineAttention deficit hyperactivity disorderADHD0501 psychology and cognitive sciencesPsychiatryRC346-429child and adolescentguanfacineOriginal Researchbusiness.industryMethylphenidate05 social sciencesAtomoxetinetrialmedicine.disease030227 psychiatryGuanfacineinadequate respondersStimulantNeurology. Diseases of the nervous systembusinessGXRatomoxetine050104 developmental & child psychologymedicine.drugRC321-571
researchProduct

Placebo and Nocebo Effects Across Symptoms: From Pain to Fatigue, Dyspnea, Nausea, and Itch

2019

Contains fulltext : 208540.pdf (Publisher’s version ) (Open Access) Placebo and nocebo effects are, respectively, the helpful and harmful treatment effects that do not arise from active treatment components. These effects have thus far been researched most often in pain. It is not yet clear to what extent these findings from pain can be generalized to other somatic symptoms. This review investigates placebo and nocebo effects in four other highly prevalent symptoms: dyspnea, fatigue, nausea, and itch. The role of learning mechanisms (verbal suggestions, conditioning) in placebo and nocebo effects on various outcomes (self-reported, behavioral, and physiological) of these different somatic s…

medicine.medical_specialtyNoceboNausealcsh:RC435-571Reviewplacebo and nocebo effectsPlacebo03 medical and health sciences0302 clinical medicinesuggestionconditioninglcsh:PsychiatryHeart ratemedicinepainitchLung functionPsychiatrybusiness.industrydyspneanausea030227 psychiatry3. Good healthNocebo EffectPsychiatry and Mental healthPhysical therapyInflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5]fatigueActive treatmentmedicine.symptombusiness030217 neurology & neurosurgery
researchProduct

Insomnia in obsessive-compulsive disorder: A Swedish population-based cohort study.

2020

Abstract Background The association between specific psychiatric disorders and insomnia is well established, but the prevalence of insomnia in obsessive-compulsive disorder (OCD) is unknown. This population-based study examined the prevalence of insomnia in patients with OCD compared to unaffected individuals from the general population and to their unaffected full siblings, and evaluated the contribution of psychiatric comorbidities to this association. Methods Individuals diagnosed with OCD (31,856) were identified from a cohort of 13,017,902 individuals living in Sweden anytime during 1973 and 2013. Logistic regression analyses were used to investigate the odds of insomnia in individuals…

medicine.medical_specialtyObsessive-Compulsive DisorderPopulationComorbidityLogistic regressionOddsCohort Studies03 medical and health sciences0302 clinical medicineSleep Initiation and Maintenance Disordersmental disordersInsomniamedicineHumanseducationPsychiatryDepression (differential diagnoses)Swedeneducation.field_of_studybusiness.industry030227 psychiatryPsychiatry and Mental healthClinical PsychologyPharmaceutical PreparationsCohortAnxietymedicine.symptombusiness030217 neurology & neurosurgeryCohort studyJournal of affective disorders
researchProduct

Recent Insights Into Cyberchondria.

2020

Purpose of Review The construct of cyberchondria was introduced relatively recently. This article aims to review the conceptualization, theoretical basis and correlates of cyberchondria, as well as its prevention and management. Recent Findings Although there is no consensus, most definitions of cyberchondria emphasize online health research associated with heightened distress or anxiety. The two theoretical models of cyberchondria involve reassurance seeking and specific metacognitive beliefs. Cyberchondria has relationships with health anxiety, problematic Internet use and symptoms of obsessive-compulsive disorder, with public health implications pertaining to functional impairment and al…

medicine.medical_specialtyObsessive-Compulsive DisorderTheoretical modelsMetacognitionAnxiety Disorders (A Pelissolo Section Editor)AnxietyCyberchondriaReassurance seeking03 medical and health sciences0302 clinical medicineHealth anxietymedicineHumansPsychiatryInternetConceptualizationPublic healthUncertaintyCOVID-19Compulsivitymedicine.diseaseAnxiety DisordersProblematic Internet use030227 psychiatryHypochondriasisCoronavirusPsychiatry and Mental healthDistressAnxiety1103 Clinical Sciences 1109 Neurosciences 1701 PsychologyCyberchondriaOnline health researchmedicine.symptomPsychologyConstruct (philosophy)030217 neurology & neurosurgeryClinical psychologyCurrent psychiatry reports
researchProduct

Consumo de sustancias en jóvenes adultos con TDAH: comorbilidad y síntomas de inatención e hiperactividad/impulsividad

2016

Young adults with attention deficit hyperactivity disorder (ADHD) are at high risk of substance use (SU). The aims of the current study were: 1) to examine the use of alcohol, tobacco, marijuana and other illegal drugs by adults with and without ADHD; 2) to compare the oppositional, conduct, anxiety, depression, sleep and antisocial personality symptoms of ADHD adults with SU and ADHD adults without SU; 3) to examine the ability of ADHD symptoms and conduct problems to predict SU. A total of 93 young adults, 43 without ADHD and 50 with a childhood diagnosis of ADHD, who were part of the Spanish sample of the Multicenter ADHD Genetics (IMAGE) study, collaborated in a follow-up evaluation 10.…

medicine.medical_specialtyOriginal articleExternalizationlcsh:BF1-990substance useSubstance useAffect (psychology)behavioral disciplines and activitiesOppositional defiant disorderConduct disorderEx post facto study03 medical and health sciences0302 clinical medicinemental disordersmedicineAttention deficit hyperactivity disorderADHD0501 psychology and cognitive sciencesTDAHestudio ex post factoYoung adultex post facto studyPsychiatryDepression (differential diagnoses)conduct disorder05 social sciencesconsumo de sustanciasmedicine.diseaseComorbidity030227 psychiatryClinical Psychologylcsh:Psychologyoppositional defiant disordertrastorno de conductaAnxietytrastorno negativista desafiantemedicine.symptomSubstance usePsychology050104 developmental & child psychology
researchProduct

FOXP2 and language alterations in psychiatric pathology

2019

Background. From the first reports of the linguist Noam Chomsky it has become clear that the development of language has an important genetic component. Several reports in families have shown the relationship between language disorders and genetic polymorphisms. The FOXP2 gene has been a fundamental piece for the understanding of language development. This gene codes for a transcription factor containing a forkhead domain of DNA binding and participates in the regulation of the expression of a large number of genes involved in the embryonic development of fundamental neuronal structures needed for the development of speech and language. Objective. To present an updated view of the relations…

medicine.medical_specialtyPathologyFOXP2 GeneFOXP2030227 psychiatry03 medical and health sciencesPsychiatry and Mental healthClinical PsychologyLanguage development0302 clinical medicineExpression (architecture)Component (UML)medicineNarrative reviewPsychologyPsychiatrySalud mental
researchProduct